Kangji Medical Holdings Limited (HKG:9997)
Hong Kong
· Delayed Price · Currency is HKD 7.39
-0.15 (-1.99%)
Apr 3, 2025, 4:08 PM HKT
Kangji Medical Holdings Revenue
In the year 2024, Kangji Medical Holdings had annual revenue of 1.01B CNY with 8.92% growth. Kangji Medical Holdings had revenue of 550.20M in the half year ending December 31, 2024, with 21.18% growth.
Revenue
1.01B CNY
Revenue Growth
+8.92%
P/S Ratio
8.10
Revenue / Employee
1.00M CNY
Employees
1,007
Market Cap
8.93B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| WuXi Biologics | 19.87B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 30.72B |